Zhejiang Orient Gene Biotech Co Ltd Capital Reinvestment Ratio
Zhejiang Orient Gene Biotech Co Ltd capital reinvestment ratio. Zhejiang Orient Gene Biotech Co Ltd (688298) has a Capital Reinvestment Ratio of 0.39x as of September 2022, meaning it reinvests 0% of its operating cash flow (CN¥309.89 Million) in capital expenditures (CN¥119.58 Million). See how much free cash does Zhejiang Orient Gene Biotech Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Capital reinvestment ratio of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2022. This chart tracks Zhejiang Orient Gene Biotech Co Ltd's Capital Reinvestment Ratio across 7 annual periods. See Zhejiang Orient Gene Biotech Co Ltd (688298) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Zhejiang Orient Gene Biotech Co Ltd Capital Reinvestment Ratio by Year (2016–2022)
Zhejiang Orient Gene Biotech Co Ltd capital reinvestment ratio by year from 2016 to 2022. For the full cash flow conversion analysis, see 688298 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.35x | CN¥3.00 Billion | CN¥1.05 Billion | ▲ +259.8% |
| 2021 | 0.10x | CN¥5.20 Billion | CN¥507.87 Million | ▲ +37.7% |
| 2020 | 0.07x | CN¥1.79 Billion | CN¥126.93 Million | ▼ -67.7% |
| 2019 | 0.22x | CN¥54.21 Million | CN¥11.90 Million | ▼ -48.5% |
| 2018 | 0.43x | CN¥44.33 Million | CN¥18.88 Million | ▲ +6.7% |
| 2017 | 0.40x | CN¥33.54 Million | CN¥13.38 Million | ▲ +1.3% |
| 2016 | 0.39x | CN¥11.81 Million | CN¥4.65 Million | — |